Apton Biosystems Appoints John W. Hanna as Chief Executive Officer and Board Director

PLEASANTON, Calif.: PLEASANTON, Calif., June 2, 2021 /PRNewswire-PRWeb/ -- Apton Biosystems, Inc., a developer of Super-Res™ sequencing instruments for large-scale clinical applications such as early cancer detection and population sequencing, today announced the appointment of John W. Hanna as chief executive officer and board director. Mr. Hanna has more than...

Click to view original post